Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0851184 (
thinning
)
11,252
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Large changes in the rheology of high-internal phase aqueous-in-oil emulsions (HIPEs) using an oil-soluble polyisobutylene-based primary surfactant (PIBSA) are provoked by very small quantities of water-soluble polyamide-based cosurfactants (
PAM
with C(12), C(14), and C(16) tails). The structural origin of this was studied using small-angle neutron scattering (SANS) from sheared emulsions, with simultaneous in situ rheology measurements. The
PAM
drastically lowers the droplet-oil interfacial tension by displacing PIBSA, causing large droplet deformation under shear and much lowered emulsion yield stress. With
PAM
, the surfactant monolayer at the droplet surface becomes more responsive to droplet shape change and redistributes in response to shear which the PIBSA-only system does not. Although it is oil-insoluble,
PAM
also reaches the nanoscale PIBSA micelles in the oil phase, changing micelle size and content in ways predictable from the hydrophilicity of the different PAMs.
PAM
does not, however, strongly affect the viscosities at high shear rates; shear
thinning
and thickening are unaffected. Droplet size, droplet-droplet flattening, and linkage determine the viscosities observed, more so than droplet-oil interfacial tension. We infer from this that the droplet motion under shear does not involve much transient droplet deformation as the droplets move by each other.
...
PMID:High internal phase emulsions under shear. Co-surfactancy and shear stability. 2150 Jul 97